Oncology Medical News about Bone Cancer Pain

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bone Cancer Pain
Pain: Clinical Updates (IASP’s clinical newsletter), 06/25/09

Jimenez-Andrade JM et al. - Over the last decade, progress has been made in laying the foundation for a mechanism-based understanding of the factors that drive bone cancer pain. Interestingly, several therapies that attenuate bone cancer pain may also reduce tumor growth and tumor-induced bone remodeling. Thus, bisphosphonates are commonly used to treat bone cancer pain, and other therapies including denosumab (anti-RANKL; Amgen), tanezumab (anti-NGF; Pfizer), and pregabalin (Pfizer) are in mid- to latestage clinical trials. Currently, we are beginning to understand the mechanisms that drive bone cancer. If this progress can be sustained and expanded, these advances have the potential to enlarge the repertoire of therapies available to treat bone cancer pain and significantly improve the quality of life, functional status, and survival of patients with bone cancer.

<< Previous
Pediatric Cancer Pain Management At A Regional Cancer Center:...

Next >>
Provider Monitoring and Pay-for-Performance When Multiple...